Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

COMT inhibition as a potential therapeutic strategy for schizophrenia

May 29, 2008

Recent Tokuyama patent discloses novel therapeutic agents for nausea

May 28, 2008

DSMB recommends continuation of BioMS's MINDSET-01 trial of dirucotide in MS

May 28, 2008

Recent Gruenenthal patents report novel analgesic agents

May 27, 2008

First MS therapeutic from Novartis approved for launch in Europe

May 26, 2008

ProStrakan grants exclusive license to JapanBridge for Sancuso in parts of Asia

May 26, 2008

Allon completes dosing in phase II AL-208 cognitive impairment trial

May 26, 2008

ST-2472 exhbits potent antipsychotic effects and good safety profile in vivo

May 26, 2008

Novel treatments for neurological disorders reported in recent patent literature

May 23, 2008

New phase III data reported for Q-8003IR dual opioid therapy

May 23, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...